Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer TherapyDavid A. Knorr, Dan S. Kaufman|Stem Cells Translational Medicine|2013Cited by 413
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor MicroenvironmentDavid A. Knorr, Jeffrey V. Ravetch|Cancer Immunology Research|2023Cited by 31